Equity Details
Price & Market Data
Price: $1.24
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $966,050,112
Daily Volume: 0
Performance Metrics
1 Week: -24.16%
1 Month: -29.14%
3 Months: -42.86%
6 Months: -18.95%
1 Year: 35.82%
YTD: -32.97%
About Pharming Group N.V. (PHGUF)
Full market details for Pharming Group N.V. (PHGUF). Current price: 1.24, daily change: $0.00 / 0.00%. Market cap: 966,050,112. Comprehensive performance data across all periods.
Details
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.